Trandate
4 customer reviewsTrandate is a brand of labetalol hydrochloride, an alpha- and beta-adrenergic blocker. It is for adults who need blood pressure control, including pregnancy-related hypertension under specialist care. It lowers blood pressure by blocking alpha and beta receptors to relax blood vessels and reduce the heart’s workload.
What is it?
Trandate contains labetalol, supplied as Labetalol Hydrochloride, and it belongs to the group of alpha- and beta-adrenergic blockers. In practice, it’s chosen when clinicians want blood-pressure lowering that combines a “beta‑blocker effect” (slower heart rate and reduced cardiac output) with an “alpha‑blocker effect” (wider blood vessels).
Composition
Active ingredient: labetalol hydrochloride (amount per tablet depends on the prescribed strength). Excipients may include common tablet fillers and binders such as lactose, starch/cellulose derivatives, povidone, magnesium stearate, and coating agents, varying by manufacturer.
How to use?
Typical oral dosing approach used in practice:
- Starting dose is often 100 mg twice daily.
- Dose increases may be made in steps, often every 2–3 days, until the target blood pressure is reached.
- A commonly cited maximum is 2400 mg per day, divided into multiple doses.
How does it work?
- Route: oral (tablets), swallow with water
- Dose: 100–200 mg per dose; typical total 200–400 mg/day; may be increased as prescribed up to 2,400 mg/day
- Frequency: 2 times/day (some regimens may be 3 times/day if directed)
- Timing: take at the same times each day; take with food to reduce dizziness
- Duration: long-term treatment as prescribed; do not stop abruptly without medical advice
Indications
Common clinical uses include:
- Chronic high blood pressure requiring ongoing control
- Hypertension when a combined alpha/beta blocker is preferred
- Pregnancy-related hypertension in specialist care
- Emergency treatment of hypertension when rapid control is needed (usually in monitored settings)
Trandate in Pregnancy
Trandate is widely used in clinical practice for gestational hypertension and pre-eclampsia management when a clinician decides labetalol is appropriate. Doctors often prefer it because it lowers blood pressure without reducing uteroplacental blood flow to the same extent as some alternatives, and it has a long track record in obstetric medicine. Dose selection and monitoring are stricter in pregnancy, because symptoms like dizziness can overlap with pregnancy-related changes and may be missed.
Trandate for Hypertensive Emergencies
Trandate can be used for emergency treatment of hypertension, including hypertensive crises, when clinicians need blood pressure reduction with heart-rate control. In these situations, hospital teams may use labetalol in protocols that involve close monitoring of blood pressure, heart rhythm, and symptoms to avoid an excessive drop. The EMA includes labetalol among established antihypertensive therapies used across different care levels in Europe, with use guided by patient factors and setting [2].
Comparison
Trandate is a brand of Labetalol Hydrochloride. Generic drugs labelled as labetalol contain the same active ingredient and are expected to deliver the same therapeutic effect when used at equivalent doses.
Contraindications
- bronchial asthma or significant COPD with bronchospasm risk
- cardiogenic shock
- decompensated heart failure
- sinoatrial block, significant heart block, or severe bradycardia
- severe hypotension
- hypersensitivity/allergy to labetalol
Not recommended for
Do not use Trandate if you have a history of asthma or COPD with wheeze, if you have certain serious heart rhythm or pumping problems, if your blood pressure is already very low, or if you have ever had an allergic reaction to labetalol. Seek medical advice urgently if you develop wheezing, fainting, or signs of liver trouble such as dark urine or yellowing of the skin or eyes.
Side effects
Most side effects relate to the intended effect: lowering blood pressure and blunting adrenaline responses. Many people feel them most when treatment begins or after a dose increase.
Common side effects seen in practice include:
- Dizziness or light-headedness, often when standing up quickly
- Fatigue or low energy
- Nausea or stomach upset
- Nasal congestion
- Bradycardia (a slower pulse than usual)
Less common but important side effects:
- Wheezing or bronchospasm, more likely in asthma or COPD
- Marked slowing of heart rate, fainting, or worsening heart failure symptoms
- Liver-related reactions (uncommon): new dark urine, persistent upper abdominal pain, yellowing of skin/eyes
A nuance from day-to-day counselling: patients sometimes label the first-week tiredness as “depression,” then stop the medicine abruptly. Timing matters. If fatigue peaks 2–4 hours after dosing, clinicians may adjust the schedule rather than abandoning the drug.
Common mistakes
Small mistakes can turn a well-tolerated blood pressure medicine into a frustrating experience.
Common problems I see in practice:
- Doubling up after a missed dose, then feeling faint later the same day
- Standing up quickly in the first week, then assuming the medicine is “too strong”
- Ignoring wheeze or chest tightness in people with asthma or COPD history
- Stopping suddenly after feeling tired, which can trigger rebound high blood pressure in some patients
- Using decongestant cold medicines (sympathomimetics) that push blood pressure up and counteract treatment
A simple habit helps: take Trandate the same times each day, and document any dose changes and readings in a short note on your phone. It makes follow-ups faster and safer.
Doctor opinions
In clinics, doctors often choose Trandate when they want one medicine to cover both vascular resistance and heart rate, rather than combining a pure beta blocker with a separate vasodilator. Cardiologists also pay attention to the “feel” of therapy: some patients report fewer pounding-heart episodes on labetalol, while others dislike the reduced exercise tolerance.
Obstetric physicians in the UAE frequently keep labetalol as a first-line option for pregnancy-related hypertension, with careful monitoring for symptoms that overlap with pregnancy itself, such as fatigue and dizziness. Internists also watch liver enzymes when symptoms suggest hepatic irritation, because labetalol has rare liver-related reactions that should be picked up early. These patterns align with the way hypertension medicines are handled in international guidance and pharmacovigilance frameworks, including WHO safety monitoring principles [3].
Frequently asked questions
For oral labetalol, blood pressure lowering can begin within hours, with steadier control developing over days as the dose is titrated. Many clinicians assess the true “working dose” over 1–2 weeks, because early readings can be influenced by stress, posture, and salt intake. If the dose is increased, side effects like dizziness may reappear briefly at the new level. MOHAP care pathways for hypertension in 2026 emphasise titration and monitoring rather than judging control from one reading [4].
Alcohol can add to Trandate’s blood-pressure lowering, which increases the chance of dizziness, especially when standing. This effect is most noticeable early in treatment or after a dose increase. If you choose to drink, many patients do better with small amounts and with food, and they avoid driving if they feel light-headed. WHO clinical safety advice on cardiovascular medicines highlights avoiding additive hypotension triggers when initiating therapy [5].
The usual approach is to take the missed dose when you remember, then continue the next dose at the regular time. Taking two doses together can cause a bigger blood pressure drop and a slow pulse later the same day. If you miss doses repeatedly, blood pressure can rebound upward and control becomes unpredictable. Keeping a simple reminder and checking blood pressure trends helps clinicians adjust the plan without overcorrecting.
Yes. Because labetalol blocks beta receptors, your maximum exercise heart rate may be lower, and intense workouts can feel harder at the same pace. This is expected and does not automatically mean your fitness declined, but it may change how you judge effort; using perceived exertion or pace can be more reliable than heart-rate targets. If you experience chest pain, faintness, or unusual shortness of breath, clinicians treat that as a reason to reassess therapy and cardiac risk.
Yes, Trandate (labetalol) is widely used in pregnancy-related hypertension under obstetric supervision, including pre-eclampsia management. The clinical aim is to lower maternal blood pressure enough to reduce stroke risk while maintaining stable placental perfusion. Monitoring is tighter, because symptoms like headache and visual changes can signal disease progression rather than medication side effects. Many guidelines used internationally list labetalol among standard options in this setting.
It can. Even though labetalol also has alpha-blocking effects, it still blocks beta receptors and may provoke bronchospasm in susceptible people. Wheeze, chest tightness, or shortness of breath after starting therapy should be treated as a serious signal, especially in anyone with asthma or COPD history. Clinicians often choose a different blood pressure class if bronchospasm risk is significant.
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Trandate — Comparison with alternatives
Reviews and Experiences
Sources
- MOHAP (Ministry of Health and Prevention) (2026). National guidance framework for hypertension management and patient safety in the UAE. ↑
- European Medicines Agency (EMA) (2026). Labetalol: regulatory summary and pharmacology overview for antihypertensive use. ↑
- World Health Organization (WHO) (2026). Pharmacovigilance and safety monitoring guidance for cardiovascular medicines. ↑
- MOHAP (Ministry of Health and Prevention) (2026). Hypertension care pathway: titration, monitoring, and follow-up standards. ↑
- World Health Organization (WHO) (2026). Clinical safety advice on additive hypotension risks with antihypertensive therapy. ↑